+499.5%
MRNA vs SPXS
-40.2%
+539.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPXS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.3% | -3.5% | -1.4% |
| 7D | +5.5% | -0.1% | +5.6% | +5.3% |
| 30D | +158.7% | +0.8% | +157.9% | +162.2% |
| 3M | +182.1% | -4.7% | +186.8% | +181.7% |
| 6M | +151.8% | -29.6% | +181.4% | +116.1% |
| YTD | +393.6% | -29.8% | +423.4% | +323.1% |
| 1Y | +499.5% | -38.9% | +538.4% | +352.6% |
| All | +499.5% | -40.2% | +539.7% | +352.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SPXS.
Daily Out/Under-Performance
Portfolio return minus SPXS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPXS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPXS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling